Síndrome da tensão pré-menstrual – o estado atual dos conhecimentos
Conteúdo do artigo principal
Resumo
A síndrome da tensão pré-menstrual (STPM) envolve a presença de sintomas físicos e comportamentais na segunda metade do ciclo menstrual, que freqüentemente comprometem a boa qualidade do desempenho profissional e dos relacionamentos pessoais. Acomete aproximadamente 40% das mulheres entre 15 e 45 anos de idade. Desequilíbrio entre estrogênio e progesterona, excesso de prolactina, deficiência de vitaminas B6 e E, atividade inapropriada de prostaglandina e alterações na ação das endorfinas e serotonina são alguns dos fatores freqüentemente relacionados à sua ocorrência. O diagnóstico baseia-se exclusivamente no quadro clínico e o tratamento envolve a mudança de hábitos comportamentais, como a realização de atividade física regular e a ingestão de uma dieta rica em proteínas e pobre em sal na segunda fase do ciclo e, também, o uso de medicamentos, tais como diuréticos, antidepressivos, progesterona ou fitoterápicos.
Downloads
Detalhes do artigo
Referências
Frank RT. The hormonal causes of premenstrual tension. Arch Neurol Psychol 1931;126:1052. http://dx.doi.org/10.1001/archneurpsyc.1931.02230110151009
Dalton K. The premenstrual syndrome and progesterone therapy. London: William Heinemann Medical Books: 1973.
Reid RL, Yen SSC. Premenstrual syndrome. Am J Obstet Gynecol 1981;139:85.
Steege JR, Stout AL, Knight DL, Nemeroff CB. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am J Obstet Gynecol 1992;167:168. http://dx.doi.org/10.1016/S0002-9378(11)91653-6
Chan AF, Mortola JF, Wood SH, Yen SSC. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol 1994;84:1001.
Chuong CJ, Hsi BP, Gibbons WE. Periovulatory bendorphin levels in premenstrual syndrome. Obstet Gynecol 1994;83:755.
Halbreich U, Rojansky N, Palter S. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 1991;56:1066.
O'Brien PM. The premenstrual syndrome: a review of the present status of therapy. Drugs 1982;24:140. http://dx.doi.org/10.2165/00003495-198224020-00004
Freeman EW, Sondheimer SJ, Rickels K. Effects of medical history factors on symptoms severity in women meeting criteria for premenstrual syndrome. Obstet Gynecol 1988;72:236.
Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/ progestin. J Clin Endocrinol Metab 1991;71:252A. http://dx.doi.org/10.1210/jcem-72-2-252
Rapkin AJ, Chang LI, Reading AE. Mood and cognitive style in premenstrual syndrome. Obstet Gynecol 1989;74:644.
Plouffe L JR, Stewart K, Craf t KS. Diagnostic and treatment results from a southeastern academic center-based premenstrual syndrome clinic: the first year. Am J Obstet Gynecol 1993;169:295. http://dx.doi.org/10.1016/0002-9378(93)90079-X
Nikolai TF, Mulligan GM, Gribble RK. Thyroid function and treatment in premenstrual syndrome. J Clin Endocrinol Metab 1990;70:1108. http://dx.doi.org/10.1210/jcem-70-4-1108
Morton JH, Additon H, Addison RG. A clinical study of premenstrual tension. Am J Obstet Gynecol 1953;65:1182.
Adams PW, Rose DP, Folkard J. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet 1973;1:897. http://dx.doi.org/10.1016/S0140-6736(73)91359-7
Abraham GE, Hargrove JT. Effect of vitamin B6 on premenstrual symptomatology in women with premenstrual tension syndrome: a double blind crossover study. Infertility 1980;3:155.
Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. J R Coll Gen Pract 1989;39:364.
ACOG Committee on Practice Bulletins-Gynecology. Premenstrual syndrome. In: ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists: 2000, cap 15:p. 1-8.
Brown CS, Freeman EW, Ling FW. An update on the treatment of premenstrual syndrome. Am J Man Care 1998;4:115-24.
Watson NR, Studd JWW, Savvas M. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;2:730. http://dx.doi.org/10.1016/S0140-6736(89)90784-8
Collins A, Cerin A, Coleman G, Landgren B-M. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993;81:93-8.
Budeiri D, LI Wan PO A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Controlled Clin Trials 1996;17:60-8. http://dx.doi.org/10.1016/0197-2456(95)00082-8
London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987;32:400-4.
Smith S. Treatment for the physical symptoms of premenstrual syndrome. In: Smith S, Schiff I, editors. Modern management of premenstrual syndrome. New York, NY: Norton & Co: 1993, p. 112-9.
Freeman EW, Rickels K, Sondheimer SJ, Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry, 1999;56(10):932-9. http://dx.doi.org/10.1001/archpsyc.56.10.932